Defining a Cancer Dependency Map

Tsherniak, Aviad, Vazquez, Francisca, Montgomery, Phil G., Weir, Barbara A., Kryukov, Gregory, Cowley, Glenn S., Gill, Stanley, Harrington, William F. +17 more·2017·Cell
DOI 10.1016/j.cell.2017.06.010

Cited by (1,075)

Items 301–400 of 1,075

  1. UniPert-G2CP bridges genetic and chemical screens from molecular representation to phenotype modeling
    Yiming Li, Min De ZENG, Jun Zhu, Linjing Liu, Fang Wang, L L Huang, Fan Yang, Min Li, Jianhua Yao · 2026 · Cell
  2. A Framework for Autonomous AI-Driven Drug Discovery
    Douglas W. Selinger, Timothy R. Wall, Eleni S. Stylianou, Ehab M. Khalil, Jedidiah Gaetz, Oren Levy · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  3. TMEM11 promotes cisplatin resistance by inhibiting BNIP3-mediated mitophagy in bladder cancer.
    Yuan Huang, Chen Chen, Ming-Qiang Su, W. Ye, Shu Wei, Kuangye Long, Yun-Jie Huang, Haiyong Chen, Zhangfeng Zhong, Li-Na Hou et al. · 2026 · Cancer Letters
  4. Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors
    Vignesh Shanmugam, Neriman Tokcan, Daniel Chafamo, Sean Sullivan, Mehdi Borji, Haley K. Martin, Gail A. Newton, Naeem M. Nadaf, Saoirse Hanbury, Irving Barrera et al. · 2025 · Nature Communications
  5. Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer
    Betul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altıntaş, Ahmet Cingöz, Emirhan Tekoglu, Ivan Pak Lok Yu, Ugur Meric Dikbas, Olka Missaghimamaghani, Kerim Yavuz, Hans H. Adomat et al. · 2025 · Proceedings of the National Academy of Sciences
  6. Rewiring the Fusion Oncoprotein EWSR1::FLI1 in Ewing Sarcoma with Bivalent Small Molecules
    Michael J. Bond, Ryan P. Golden, Giulia DiGiovanni, Briana Howard, Roman C. Sarott, Basel A. Karim, Sai P. Gourisankar, Gabriela Alexe, Kenneth N. Ross, Hannah M. Jones et al. · 2025 · Journal of the American Chemical Society
  7. Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery
    Aleksandr Ianevski, Kristen Michelle Nader, Julia Nguyen, Helena Sorger, Sanna H. Timonen, Edith Julia, Daniel Pölöske, Katrin Spirk, Christina Wagner, Dennis Jungherz et al. · 2025 · Cancer Research
  8. RNase MRP subunit composition and role in 40S ribosome biogenesis
    Eric M. Smith, Jimmy Ly, Sofia Haug, Iain M. Cheeseman · 2025 · Nature Structural & Molecular Biology
  9. Mechanistically informed machine learning links non-canonical TCA cycle activity to Warburg metabolism and hallmarks of malignancy
    Li-Hao Lin, Francesco Lapi, B. Galuzzi, Marco Vanoni, L. Alberghina, Chiara Damiani · 2025 · bioRxiv
  10. Integrator promotes the association of TFIID and RNA polymerase II to maintain pluripotency during development
    Raghu R. Edupuganti, F. Beckedorff, P. Cingaram, S. Parast, Jing-Yin Yue, G. Leroy, M. Valencia, Sadat Dokaneheifard, Helena Gomes Dos Santos, Omar López Ocejo et al. · 2025 · Molecules and Cells
  11. Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolbox
    Megan D. Schertzer, Andrew Stirn, Keren Isaev, Laura Pereira, S H Park, Anjali Das, Aline Réal, Erin D. Jeffery, Claire Harbison, Hans‐Hermann Wessels et al. · 2025 · Nature Communications
  12. Systematic comparison and base-editing-mediated directed protein evolution and functional screening yield superior auxin-inducible degron technology
    De Xing, Tao Bai, Ozlem Neyisci, Seyedehzahra Paylakhi, A. Duval, Yasemin Tekin, M. Adli · 2025 · Nature Communications
  13. A global genetic interaction map of a human cell reveals conserved principles of genetic networks
    Maximilian Billmann, Michael Costanzo, Xiang Zhang, Arshia Zernab Hassan, Mahfuzur Rahman, Kevin R. Brown, Katherine Chan, Amy H.Y. Tong, Carles Pons, Henry N. Ward et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Mutant CEBPA promotes tolerance to inflammatory stress through deficient AP-1 activation
    Maria Cadefau-Fabregat, Gerard Martínez-Cebrián, Lucía Lorenzi, Felix D. Weiss, Anne-Katrine Frank, José Manuel Castelló-García, Eric Julià-Vilella, Andrés Gámez-García, Laura Yera, Carini Picardi Morais de Castro et al. · 2025 · Nature Communications
  15. Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma
    Cristina Salmerón, Elena Tomás Bort, Krishna Sriram, Mehrak Javadi Paydar, Jane E. Smitham, Kimberly Pham, Richard Philip Grose, Peter James McCormick, Anna Di Nardo, Jonathan Weitz et al. · 2025 · Journal of Pharmacology and Experimental Therapeutics
  16. Cancer-intrinsic Cxcl5 orchestrates a global metabolic reprogramming for resistance to oxidative cell death in 3D
    Ramin Seo, Arvie Camille V. de Guzman, Sunghyouk Park, Ji Youn Lee, Suk‐Jo Kang · 2025 · Cell Death and Differentiation
  17. Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma
    Yi-Jian Zheng, Xiao-Yu Li, Lina Ma, Siying Wang, H. Du, Yun Wu, Jing Yu, Y. Xiang, Dai-Qin Xiong, Huiting Shan et al. · 2025 · Cancer Immunology and Immunotherapy
  18. Calcium sensing receptor stimulates breast cancer cell migration and invasion via Protein Kinase C ζ.
    Safir Ullah Khan, Rodolfo Daniel Cervantes-Villagrana, Jorge Eduardo del Río-Robles, Janik Adriana Tomás-Morales, Yazmin Torres-Santos, J. Vázquez-Prado, Guadalupe Reyes-Cruz · 2025 · Experimental Cell Research
  19. Leveraging AI to automate detection and quantification of extrachromosomal DNA to decode drug responses
    Kohen Goble, Aarav Mehta, Damien Guilbaud, Jacob Fessler, Jing-Ting Chen, William Nenad, Christina G. Ford, O. Cope, Darby Cheng, William Dennis et al. · 2025 · Frontiers in Pharmacology
  20. Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development
    Han Koo, K. Park, H. Sohn, Min-Ho Kang, Dong Joon Kim, Zee-Yong Park, Sehoon Park, Sang-Hyun Min, Seong-Hwan Park, Yeon-Mi You et al. · 2025 · Nature Communications
  21. Scaling up drug combination surface prediction
    Riikka Huusari, Tianduanyi Wang, S. Szedmák, Diogo Dias, T. Aittokallio, Juho Rousu · 2024 · bioRxiv
  22. Integrative proteomic characterization of human lung adenocarcinoma with KRAS G12 mutations reveals molecular pathogenesis
    Shi, Xinyu, Hu, Liling, Huang, Yongshi, Zhang, Mei-Fang, Ying, Xingfeng, Yuan, Xiaoyi, Wen, Nengqiao, Lu, Jiangli, Zou, Hanchen, Tan, Xiaohui et al. · 2026 · Journal of Advanced Research
  23. O-GlcNAcylation of FOXK1 co-opts BAP1 to orchestrate the E2F pathway and promotes oncogenesis
    2025
  24. Allosteric activation of the SPRTN protease by ubiquitin maintains genome stability
    Dürauer, Sophie, Kang, Hyun-Seo, Wiebeler, Christian, Machida, Yuka, Schnapka, Dina S., Yaneva, Denitsa, Renz, Christian, Götz, Maximilian J., Weickert, Pedro, Major, Abigail C. et al. · 2025 · Nature Communications
  25. RNA-coupled CRISPR screens reveal ZNF207 as a regulator of LMNA aberrant splicing in progeria
    Behera, Amit K., Kim, Jeongjin J., Kordale, Shreya, Pekovic, Filip, Damodaran, Arun Prasath, Kumari, Bandana, Vidak, Sandra, Dickson, Ethan, Xiao, Mei-Sheng, Duncan, Gerard et al. · 2026 · Molecular Cell
  26. O-GlcNAcylation of FOXK1 orchestrates the E2F pathway and promotes oncogenesis
    Masclef, Louis, Ahmed, Oumaima, Iannantuono, Nicholas, Gagnon, Jessica, Gushul-Leclaire, Mila, Boulay, Karine, Estavoyer, Benjamin, Echbicheb, Mohamed, Poy, Marty, Ali Boubacar, Kalidou et al. · 2024
  27. The EFFECT benchmark suite: measuring cancer sensitivity prediction performance - without the bias
    Szalai, Bence, Gáspár, Imre, Kaszás, Valér, Mérő, László, Sztilkovics, Milán, Szalay, Kristóf Z. · 2023
  28. Engineered protein circuits for cancer therapy
    Andrew C. Lu, Lukas Moeller, Stephen Moore, Kevin Ho, Victoria Tobin, Albert Qiang, Evan Zhang, Zhijie Li, Mengmeng Wang, Shiyu Xia et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  29. A dependency map enhanced with next-generation 3D cancer models
    James V. Neiswender, Samuel Maffa, Lisa Brenan, Dina ElHarouni, Yejie Yun, Isabella Boyle, Kirsty Wienand, Haider Inam, Tate Bertea, Ashley Anderson et al. · 2026 · Nature
  30. Hierarchical small molecule inhibition of MYST acetyltransferases
    Xuemin Chen, A. Castroverde, Minervo Perez, R. Holewinski, Kiall F. Suazo, Rashmi Karki, T. Andresson, Benjamin A. Garcia, Jordan L. Meier · 2026 · Nature Communications
  31. Critical evaluation of drug response prediction models with DrEval
    J. Bernett, Pascal Iversen, Mario Picciani, Matthias Wilhelm, K. Baum, M. List · 2026 · Nature Communications
  32. Context-dependent synthetic lethality — an emerging precision therapeutic approach
    Liang Chang, Katharin L. Shaw, Francisca Vázquez, William R. Sellers · 2026 · Nature reviews. Cancer
  33. Microglia-mediated protection against Alzheimer’s disease pathology and detrimental effects in white matter revealed by Ptpn6 deletion
    Ainhoa Etxeberría, Seung-Hye Lee, Julia Kuhn, Marinella G. Callow, Gloriia Novikova, Jean‐Philippe Fortin, Man Kin Choy, Luke Xie, Jose Imperio, Steve Vito et al. · 2026 · Neuron
  34. Pancancer Fine‐Mapping of Mutational Intolerance Identifies CHEK1 as an Immunosuppressive Driver in Lung Adenocarcinoma
    Tao Wang, Hongyu Zhao, Xiaojie Sun, Yuqi Ding, Zhipeng Zhu, Xiaojuan Yu, Rongyi Zhu, Dan Wang, Kailong Li, Yang Liu et al. · 2026 · Advanced Science
  35. AI-driven CRISPR screening: optimizing gene editing through automation and intelligent decision support
    Yuxi Zhao, Xingrui Li, Yaying Du · 2026 · Journal of Translational Medicine
  36. Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types
    Andrew Everall, Avraam Tapinos, Aliah Hawari, Alex J. Cornish, Amit Sud, Daniel Chubb, Ben Kinnersley, Anna Frangou, Miguel Barquín, Josephine Jung et al. · 2026 · Nature Genetics
  37. Paediatric Therapeutic Development Workshop on rhabdoid tumours
    C. Montiel-Equihua, Jan J. Molenaar, Itziar Areso, J. Biegel, P. Blanc, Susan N. Chi, Sam Daems, L. Danielson, J. Drost, Niels E. Franke et al. · 2026 · British Journal of Cancer
  38. Cis and Trans Regulatory Mechanisms of ecDNA Segregation
    Yi-Peng Xie, J. Lim, Wenyue Liu, C. Gilbreath, Xiaohui Sun, Kailiang Qiao, Y. Kim, Si-Han Wu · 2026 · bioRxiv
  39. Large-scale mapping of environmental-genetic interactions illustrates the dynamic nature of cell-cycle and DNA repair regulation
    Benjamin W. Herken, Garrett T. Wong, Anna Mäkiniemi, Emma K. Lundberg, Thomas M. Norman, Luke A. Gilbert · 2026 · Molecular Cell
  40. Aspartate availability drives differential engagement of the malate-aspartate shuttle
    Julia S. Brunner, Anna E Bridgeman, Benjamin T. Jackson, Sangita Chakraborty, Maider Fagoaga-Eugui, Katrina I. Paras, Abigail Xie, Paige K. Arnold, Julia Losner, Lydia W.S. Finley · 2026 · Molecular Cell
  41. Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma
    Holly Holliday, Aaminah Khan, Anahid Ehteda, Hieu Nguyen, Samuel E. Ross, Nisitha Jayatilleke, Anjana Gopalakrishnan, Eyden Wang, Yolanda Colino‐Sanguino, Daisy Kavanagh et al. · 2026 · Science Translational Medicine
  42. Structure of SHOC2-KRAS-PP1C complex reveals RAS isoform-specific determinants and insights into targeting complex assembly by RAS inhibitors
    Daniel A. Bonsor, Lorenzo I. Finci, Jacob R. Potter, Lucy C. Young, Vanessa E. Wall, Ruby Goldstein de Salazar, Katie R. Geis, Tyler Stephens, Joe Finney, Dwight V. Nissley et al. · 2026 · Nature Communications
  43. Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition
    Di Wu, Chun-Bin Zhu, Haoqi Pan, He Xu, Jin Xu, Yang Liu, Sikai Wang, Ming-Ming Xiao, Xian-Jun Yu, S. Shi · 2026 · Gut
  44. ABCG2-Mediated SN-38 Efflux Drives Resistance to Sacituzumab Govitecan in Urothelial Carcinoma.
    I. Prantl, R. Grausenburger, Julia F. Müller, O. Baumfried, I. Ertl, Christoph Nössing, P. Herek, C. Pirker, Daniel Valcanover, Y. Bastos-Moreira et al. · 2026 · Cancer Letters
  45. Hexokinase detachment from mitochondria drives the Warburg effect to support compartmentalized ATP production
    Kimberly S. Huggler, Kyle M. Flickinger, Matthew H. Forsberg, Carlos Mellado Fritz, Gavin R. Chang, Meghan F. McGuire, Christian M. Capitini, Jason R. Cantor · 2026 · Nature Metabolism
  46. Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts.
    Xiao-Ting Jiang, Mei-Kuang Chen, Jiwang Lee, Xia-Yu Rao, Yan Wang, Linjie Luo, Jing Wang, Kelly K. Hunt, K. Keyomarsi · 2025 · Science Translational Medicine
  47. Lineage-determining transcription factors constrain cohesin to drive multi-enhancer oncogene regulation
    Yeqiao Zhou, Atishay Jay, Noah G. Burget, Tobias Friedrich, Sora Yoon, Jessica Alsing, Guy Nir, Rudolf Grosschedl, Golnaz Vahedi, Robert B. Faryabi · 2025 · Nature Cell Biology
  48. Splice-switching ASOs targeting the AURKA 5′ UTR collapse an SRSF1-AURKA-MYC oncogenic circuit in pancreatic cancer
    Alexander J. Kral, Lu Jia, GeunYoung Sim, Ledong Wan, Yuma Ishigami, Adrian R. Krainer · 2025 · Molecular Cell
  49. High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease
    Christopher L. Cardona, Lai Wei, Joonwon Kim, Ellen Angeles, Gunjandeep Singh, Shiye Chen, Ronak Patel, Nkechime Ifediora, Peter Canoll, Andrew F. Teich et al. · 2025 · Journal of Neuroinflammation
  50. Menin-MLL1 complex cooperates with NF-Y to promote hepatocellular carcinoma survival
    Margarita Dzama-Karels, Mallory Sokolowski, Peyton C. Kuhlers, Jacqueline A. Brinkman, John P. Morris, Jesse R. Raab · 2025 · Cell Reports
  51. METTL3-dependent m6A RNA methylation suppresses aberrant mammary epithelial differentiation and neoplastic transformation
    Yi-Hao Li, X. Qiu, Zachary M. Sandusky, Kaitlin Tagliaferri, Rong Li, Xin Yang, Tao Zhang, Shimeng Liu, P. Yan, Feng Lu et al. · 2025 · Proceedings of the National Academy of Sciences of the United States of America
  52. Redox destabilization by ibrutinib promotes ferroptosis in diffuse large B-cell lymphoma (DLBCL)
    Anuschka Langpape, Debora Bonasera, J. Stroh, Moritz Reese, M. Cartolano, G. Liccardi, Silvia von Karstedt · 2025 · Cell Death Discovery
  53. FTO depletion does not alter m6A stoichiometry in AML mRNA: a reassessment using direct RNA nanopore sequencing
    Luke S. Nicholson, C. Guimarães-Teixeira, J. Liu, Raymond Chien, J. Xu, Hui Xian Poh, Ying-Xian Pan, S. Jaffrey · 2025 · bioRxiv
  54. Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer
    Dennis Gong, Rachel Liu, Yi Cui, Michael Rhodes, Jung Woo Bae, J. Beechem, W. L. Hwang · 2025 · Science Advances
  55. A compendium of synthetic lethal gene pairs defined by extensive combinatorial pan-cancer CRISPR screening
    Victoria J. Harle, Victoria Offord, Birkan Gökbağ, Lazaros Fotopoulos, Thomas Williams, Diana Alexander, Ishan Mehta, Nicola Thompson, Rebeca Olvera-León, Stefan Peidli et al. · 2025 · Genome biology
  56. METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis
    Guglielmo Bove, Mehrad Babaei, Alberto Bueno-Costa, Sajid Amin, Nicla Simonelli, Rosaria Benedetti, Carmela Dell’Aversana, Mariarosaria Conte, Liliana Montella, Vincenzo Summa et al. · 2025 · Oncogene
  57. Pharmacologic interrogation of USP28 cellular function in p53 signaling
    Ariana S. Bratt, Susan Kilgas, Maria I. Tarazona Guzman, Robert S. Magin, Isabella Jaen Maisonet, Cara Ann Starnbach, Wei Pin Teh, Anthony C. Varca, Bin Hu, Esteban Tarazona Guzman et al. · 2025 · Cell chemical biology
  58. CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis
    Bo Han, Weiyang Liu, Wanhui Wang, Zhuo-Lun Li, Bo-Sen You, Dong-Ze Liu, Yunfeng Nan, Tiankai Ding, Zhou Dai, Yan-Tong Zhang et al. · 2025 · Frontiers in Immunology
  59. CRISPR-Cas9 screening identifies a gene signature predictive of prognosis in glioblastoma
    X. Ren, Xiang-Rong Yao, Kun Chen, Wen-Tao Xiao, Jun-Yan He · 2025 · Scientific Reports
  60. CRISPR GENome and epigenome engineering improves loss-of-function genetic-screening approaches
    Jannis Stadager, Chiara Bernardini, Laura Hartmann, Henrik May, Jessica Wiepcke, Monika Kuban, Z. Najafova, Steven A. Johnsen, Stefan Legewie, Franziska R. Traube et al. · 2025 · Cell Reports Methods
  61. Role of the SAF-A/HNRNPU SAP domain in X chromosome inactivation, nuclear dynamics, transcription, splicing, and cell proliferation
    J. Sharp, Emily Sparago, Rachael Thomas, Kaitlyn Alimenti, Wei Wang, Michael D. Blower · 2025 · PLoS Genetics
  62. The Prognostic Value of the Hedgehog Signaling Pathway in Ovarian Cancer
    Noor D Salman, L. Hanker, B. Győrffy, Á. Bartha, L. Proppe, M. Götte · 2025 · International Journal of Molecular Sciences
  63. A robust multiplex-DIA workflow profiles protein turnover regulations associated with cisplatin resistance and aneuploidy
    Barbora Šalovská, Wenxue Li, Oliver M. Bernhardt, Pierre‐Luc Germain, Qinyue Wang, Tejas Gandhi, Lukas Reiter, Yansheng Liu · 2025 · Nature Communications
  64. Multi-omics analysis reveals CMTR1 upregulation in cancer and roles in ribosomal protein gene expression and tumor growth
    Ion John Campeanu, Yuanyuan Jiang, Hilda Afisllari, Sijana H. Dzinic, Lisa Polin, Zeng-Quan Yang · 2025 · Cell Communication and Signaling
  65. Rapid and robust validation of pooled CRISPR knockout screens using CelFi
    Allister J. Loughran, Shilpa Narina, Jonathon D. Klein, Jamaica F. Siwak, Jon P. Connelly, Shondra M. Pruett‐Miller · 2025 · Scientific Reports
  66. Systematic genetic perturbation reveals principles underpinning robustness of the epigenetic regulatory network
    Thomas Stuart Wilson, R. Noberini, Eirini Moysidou, Ifeyinwa Ojukwu, M. Milan, Ming Jiang, Gavin P. Kelly, Michael Howell, Tiziana Bonaldi, P. Scaffidi · 2025 · Nucleic Acids Research
  67. Comparative CRISPRi screens reveal a human stem cell dependence on mRNA translation-coupled quality control
    Geraldine Rodschinka, Sergio Forcelloni, Felix M Kühner, Sascha Wani, Henrick Riemenschneider, Dieter Edbauer, Andrew Behrens, Danny D. Nedialkova · 2025 · Nature Structural & Molecular Biology
  68. Targeting USP8 causes synthetic lethality through degradation of FGFR2 in ARID1A-deficient ovarian clear cell carcinoma
    Ryosuke Saito, Makoto Fukushima, Mariko Sasaki, A. Okamoto, Hideaki Ogiwara · 2025 · npj Precision Oncology
  69. The essential clathrin adapter protein complex-2 is tumor suppressive specifically in vivo
    S. Zimmerman, L. B. DeGraw, C. Counter · 2025 · Nature Communications
  70. Genomic alterations in the WNT/β-catenin pathway and resistance of colorectal cancer cells to pathway-targeting therapies
    I. Voutsadakis · 2025 · Exploration of Targeted Anti-tumor Therapy
  71. Anticancer Activity of Enantiomeric Neplanocins A: Exploring the Role of Chirality in Tumor Suppression
    Róża Pawłowska, Hubert Banaszkiewicz, Arkadiusz Chworos, Remigiusz Żurawiński · 2025 · International Journal of Molecular Sciences
  72. EpigenPlot: An interactive web platform for DNA methylation‐based biomarker and drug target discovery in colorectal cancer
    Dalma Müller, B. Győrffy · 2025 · British Journal of Pharmacology
  73. Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment
    Roderic Espín, Ferran Medina‐Jover, Javier Sigüenza-Andrade, Sònia Farran-Matas, Francesca Mateo, Agnes Figueras, Rosario T. Sanz, Guillermo Pablo Vicent, Arzoo Shabbir, Lara Ruiz-Auladell et al. · 2025 · NAR Cancer
  74. lncRNAlyzr: Enrichment Analysis for lncRNA Sets
    John Erol Evangelista, Tahleel Ali-Nasser, Lauren E. Malek, Zhuorui Xie, Giacomo B. Marino, Assaf C. Bester, Avi Ma’ayan · 2025 · Journal of Molecular Biology
  75. A forward genetic screen identifies potassium channel essentiality in SHH medulloblastoma maintenance
    Jerry J. Fan, Anders W. Erickson, Julia Carrillo-Garcia, Xin Wang, Patryk Skowron, Xian Wang, Xin Chen, Guanqiao Shan, Wenkun Dou, Shahrzad Bahrampour et al. · 2025 · Developmental Cell
  76. CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias
    Travis J. Fleming, Mateusz Antoszewski, S. Lambo, Michael Gundry, Riccardo Piussi, Lara Wahlster, Sanjana B Shah, Fiona Reed, Kevin D. Dong, João A. Paulo et al. · 2024 · bioRxiv
  77. Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferation
    Kim, Jeeho, Jeon, Young Jin, Chang, In-Youb, Lee, Jung-Hee, You, Ho Jin · 2025 · Experimental & Molecular Medicine
  78. Tabula Sapiens 2.0: A comprehensive transcriptomic atlas of human cell types
    Robert C. Jones, Mark A. Krasnow, Angela Oliveira Pisco, Stephen R. Quake, Julia Salzman, Nir Yosef, Madhav Mantri, Anton Thieme, Jessie Aguirre, Ron Garner et al. · 2026 · Cell
  79. A CDK1 phospho-switch reprograms TRAIP to unload replisomes in mitosis
    Geylani Can, Maksym Shyian, Archana Krishnamoorthy, Samreen Ahmed, Yang Lim, Alex Wu, Raphael Pavani, Manal S. Zaher, André Nussenzweig, Markus Räschle et al. · 2026 · Science
  80. Essential lncRNAs in the human transcriptome
    Wen-Wei Liang, Simon J. Mueller, Sydney K. Hart, Hans‐Hermann Wessels, Alejandro Méndez‐Mancilla, Akash Sookdeo, Olivia Choi, Christina M. Caragine, Alba Corman, Lu Lu et al. · 2026 · Cell Genomics
  81. Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia
    Lili Ren, Honghai Zhang, O. Bobiļeva, Francesco Nai, Hongjie Bi, Anthony K. N. Chan, Genevieve E Baker, Lei Dong, David Guarin, Wei-Dong Hu et al. · 2026 · Blood
  82. A tumor-associated photoreceptor signature unifies distinct central nervous system malignancies
    Brian L. Gudenas, Shiekh Tanveer Ahmad, Bernhard Englinger, Anthony PY Liu, Miao Zhao, Leena Paul, Jennifer L. Hadley, Yiran Li, Melissa Batts, Priya Mittal et al. · 2026 · Cancer Cell
  83. Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors
    Nishma Gupta, Nicole Trainor, M. Radwan, Stephanie Nguyen, Luke Duncan, A. X. Tang, Julia Beveridge, N. Silke, Jumana M. Yousef, Ceren Bilgilier et al. · 2026 · Communications Chemistry
  84. Chitinase-3-like protein 1 depletion in glioma cells alters tumor microenvironment and normalizes neovasculature in human glioma xenografts
    S. Cyranowski, M. Zawadzka, M. Ghosh, B. Wojtaś, Anna R. Malik, K. Poleszak, K. Waśniewski, S. Baluszek, Julian Swatler, K. Wojnicki et al. · 2026 · Cell Communication and Signaling
  85. HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors
    Daniel Hwang, Molly C. Erdman, Santosh Adhikari, Ram Pantula, Kaya R. Epstein, Pei-Yao Li, F. Costabile, Photis Rotsides, Chloe S Wang, Shirley M. Sun et al. · 2026 · Science Advances
  86. Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma
    A. Sagerer, I. Eyüpoglu, T. Juratli, N. Cordes · 2025 · Frontiers in Oncology
  87. Exploring copper metabolism and cuproptosis, and their implications in ocular diseases
    Xuanrui Xiong, Qiang Li, Yuanyuan Zhang, Pan Liu, Yuxu Pan, Qiongtao Song · 2025 · European Journal of Pharmacology
  88. CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling
    Robin Minati, Maxime Cahuzac, Julie Perrault, Véronique Lullier, Anca Apavaloaei, Éric Bonneil, Mathieu Courcelles, Joël Lanoix, Eralda Kina, Claude Perreault et al. · 2025 · Cell Reports
  89. The TIM22 carrier translocase supports cell proliferation by facilitating mitochondrial iron uptake for Fe-S biogenesis
    Shuai Liu, Qingyu Li, Mengye Cao, Zefang Bimo Zhao, Cong Liu, Zhuoran Zhen, Jiankun Ren, Chengyang Liu, Danyang Ruan, Luna Zhang et al. · 2025 · Molecular Cell
  90. Nucleolar MED19 regulates 2′-O-methylation of rRNA in supporting cancer cell growth
    Ming Yang, Jiamin Zhao, Yu Peng, Chengjiang Lu, Yiyang Zhang, Han-Qing Zhang, Qiang Zhou, Gang Wang · 2025 · Nucleic Acids Research
  91. Harnessing the E3 ligase SPOP for targeted degradation of the NUP98::KDM5A fusion oncoprotein
    Ecem Kirkiz, Gabriel Kaufmann, Simone Bergqvist, Pablo Fernández‐Pernas, Thomas Eder, Laura Quell, Melanie Allram, Gabriele Manhart, Wencke Walter, Torsten Haferlach et al. · 2025 · Cell Reports
  92. From Genomic Fossils to Functional Elements: The Evolving Story of Pseudogenes
    Mengyao Sun, Yanni Ma, Jia Yu · 2025 · Advanced Genetics
  93. KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2
    Patrick J. Cunniff, N. Sivetz, D. Skopelitis, Olaf Klingbeil, Daniel Toobian, Diogo Maia-Silva, M. Egeblad, Christopher R. Vakoc · 2025 · Nature Communications
  94. HROB is a novel prognostic biomarker correlated with immune cell infiltration and tumor progression in lung adenocarcinoma
    Yongjie Zhu, Chaoqiang Wu, Qi-Wei Li, Ying Hu, Yue Li, Zuotao Wu, Honglin Lu, Ye Chen, Bo Chen · 2025 · World Journal of Surgical Oncology
  95. Integrative Multi-Omics Analyses Reveal Mechanisms of Resistance to Hsp90β-Selective Inhibition
    Ian Mersich, Eahsanul Anik, Aktar Ali, Brian S. J. Blagg · 2025 · Cancers
  96. Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer
    Daniela Ottaviani, Mihaela Ola, Alessandra Allotta, Yasmine Maati Chaibi, Seán Hickey, Petra Jagušt, Nicola S. Cosgrove, Sinéad Cocchiglia, Fiona T. Bane, Ramón Fallon et al. · 2025 · JNCI Journal of the National Cancer Institute
  97. Androgen receptor‐mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer
    Saiganesh Sriraman, Verneri Virtanen, Antti Kukkula, Mervi Toriseva, Anni Lumiainen, Gun West, Matti H. POUTANEN, Pekka Taimen, Maria Sundvall · 2025 · The Journal of Pathology
  98. Mitochondrial phosphopantetheinylation is required for oxidative metabolism
    Pieter R. Norden, Riley J. Wedan, Samuel E. J. Preston, Morgan Canfield, Naomi Graber, Jacob Z. Longenecker, Olivia A. Pentecost, Elizabeth McLaughlin, Madeleine L. Hart, S. Nowinski · 2025 · Metabolism: Clinical and Experimental
  99. Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer
    Priya S. Hibshman, Clint A. Stalnecker, Jeffrey A. Klomp, Kristina Drizyte‐Miller, Jennifer E. Klomp, A. Cole Edwards, Lily M. Pita, Richard G. Hodge, J. Nathaniel Diehl, Ryan D. Mouery et al. · 2025 · Science Signaling
  100. Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1 -Mutant Lung Cancer
    Melat T. Gebru, Timothy E. Hoffman, Aaron Boudreau, Ngoc Vu, Fei Han, Putianqi Wang, Eddie Folk, Xiumin Wu, James Newton, Kelly D. Foster-Duke et al. · 2025 · Cancer Research